Photodistributed Hyperpigmentation Induced by Lercanidipine

Abstract

Hypertension (systolic blood pressure of 140 mmHg or above
and/or diastolic blood pressure of 90 mmHg or above), is
the most common chronic condition dealt with by primary care
physicians and other health practitioners.1 Calcium channel blockers
(CCBs), introduced into clinical medicine in the 1960s, are a
group of compounds with distinctive structures and pharmacologic
effects, are first-line treatment option for hypertension.2 In
spite of their widespread use, little data have been published about
the spectrum of cutaneous adverse reactions by CCBs.3-6 Cutaneous
adverse reactions induced by lercanidipine, a third-generation
o dihydropyridine CCBs, are uncommon.7-9 We present to our
knowledge the first case of reticulated photodistributed hyperpigmentation
induced by this drug.